寶寶樹(01761.HK)與復星健康達成戰略合作 加速構建母嬰家庭幸福生態系統
寶寶樹(01761.HK)公佈與復星健康達成戰略合作協議。復星全球合夥人、寶寶樹董事會聯席主席高敏,復星全球合夥人、復星健康CEO李勝利,復星全球合夥人、復星產業互聯網事業羣聯席總裁沈?,於上海出席簽約儀式。
雙方未來將就用戶運營、C2M、O2O等多個業務板塊深化合作並持續探索,實現寶寶樹母嬰服務與復星健康核心健康服務業務的協同共進,進一步完善復星健康的全場景健康生態系統,並推動寶寶樹母嬰家庭幸福生態戰略的加速落地。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.